AllianceBernstein’s Ventyx Biosciences VTYX Stock Holding History

AllianceBernstein’s Portfolio VTYX Stock Details VTYX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-101,330	Closed	-$117K	–	3343
2025 Q1	$117K	Hold	101,330	–	–	﹤0.01%	3044
2024 Q4	$222K	Hold	101,330	–	–	﹤0.01%	3000
2024 Q3	$221K	Hold	101,330	–	–	﹤0.01%	3010
2024 Q2	$234K	Buy	101,330 +51,300	+103%	+$213K	﹤0.01%	2994
2024 Q1	$275K	Sell	50,030 -6,060	-11%	-$27.7K	﹤0.01%	2833
2023 Q4	$139K	Sell	56,090 -41,636	-43%	-$395K	﹤0.01%	3025
2023 Q3	$3.39M	Buy	97,726 +34,406	+54%	+$1.19M	﹤0.01%	1593
2023 Q2	$2.08M	Buy	63,320 +36,720	+138%	+$1.27M	﹤0.01%	1875
2023 Q1	$891K	Hold	26,600	–	–	﹤0.01%	2288
2022 Q4	$872K	Buy	26,600 +11,400	+75%	+$338K	﹤0.01%	2354
2022 Q3	$531K	Buy	+15,200	New	+$337K	﹤0.01%	2619

Other funds holding VTYX

Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

AAA

Affinity Asset Advisors New York $1.94B AUM 374.45% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

TCM

Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return

Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

VPC

Vestal Point Capital New York $3.58B AUM 189.12% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

SCM

Sio Capital Management New York $697M AUM 79.73% 1-Year Est. Return

AllianceBernstein's VTYX Position: Q2 2025 in Review

AllianceBernstein sold out of Ventyx Biosciences (VTYX) in Q2 2025, closing a stake of 101,330 shares — an estimated $117K sold.

AllianceBernstein first reported a position in VTYX in Q3 2022 and held it in 11 quarters. The position peaked at $3.39M in Q3 2023. 114 funds tracked by Wall St. Rank hold VTYX as of Q2 2025.

AllianceBernstein reported no remaining Ventyx Biosciences position as of Q2 2025 after selling out during the quarter.
AllianceBernstein sold 101,330 Ventyx Biosciences shares in Q2 2025, an estimated $117K.
AllianceBernstein first reported a position in Ventyx Biosciences in Q3 2022 and held it in 11 quarters.
AllianceBernstein's Ventyx Biosciences position peaked at $3.39M in Q3 2023.
114 funds tracked by Wall St. Rank held Ventyx Biosciences as of Q2 2025.

Based on AllianceBernstein's 13F filing for Q2 2025, filed 14 Aug 2025.